{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:59:17Z","timestamp":1722992357560},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12664-016-0687-3","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T21:17:18Z","timestamp":1473110238000},"page":"354-360","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated risk of subsequent malignancies in patients with appendiceal cancer: A population-based analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Adil","family":"Ayub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Om","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Santana-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam","family":"Raad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz Y.","family":"Bhora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"687_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/gut.4.2.158","volume":"4","author":"KT Hesketh","year":"1963","unstructured":"Hesketh KT. The management of primary adenocarcinoma of the vermiform appendix. Gut. 1963;4:158\u201368.","journal-title":"Gut"},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM198712313172704","volume":"317","author":"CG Moertel","year":"1987","unstructured":"Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317:1699\u2013701.","journal-title":"N Engl J Med"},{"key":"687_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B, et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95:135\u201356.","journal-title":"Neuroendocrinology"},{"key":"687_CR4","unstructured":"Adil SR, Meyerhardt JA. Cancer of the appendix and pseudomyxoma peritonei. In: UpToDate, Tanabe KK (Ed), UpToDate, Waltham, MA. Accessed 23 March 2016."},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archsurg.143.7.664","volume":"143","author":"CS Landry","year":"2008","unstructured":"Landry CS, Woodall C, Scoggins CR, McMasters KM, Martin RC 2nd. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg. 2008;143:664\u201370 .discussion 670","journal-title":"Arch Surg"},{"key":"687_CR6","doi-asserted-by":"crossref","unstructured":"Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. American Society of Clinical Oncology educational book \/ ASCO. American Society of Clinical Oncology. Meeting. 2014:e57\u201367.","DOI":"10.14694\/EdBook_AM.2014.34.e57"},{"key":"687_CR7","first-page":"1197","volume":"57","author":"AM Brunner","year":"2016","unstructured":"Brunner AM, Hobbs G, Jalbut MM, Neuberg DS, Fathi AT. A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database. Leuk Lymphoma. 2016;57:1197\u2013200.","journal-title":"Leuk Lymphoma"},{"key":"687_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cncr.29685","volume":"122","author":"JS Lee","year":"2016","unstructured":"Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122:116\u201323.","journal-title":"Cancer"},{"key":"687_CR9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MPH.0000000000000280","volume":"37","author":"KS Fernandez","year":"2015","unstructured":"Fernandez KS, Aldrink JH, Ranalli M, Ruymann FB, Caniano DA. Carcinoid tumors in children and adolescents: risk for second malignancies. J Pediatr Hematol Oncol. 2015;37:150\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"key":"687_CR10","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program ( www.seer.cancer.gov ) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2014 Sub (1973\u20132012)\u00a0<\u00a0Katrina\/Rita Population Adjustment\u00a0>\u00a0\u2212 Linked To County Attributes - Total U.S., 1969\u20132013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission."},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ajo.2015.07.037","volume":"160","author":"D Tamboli","year":"2015","unstructured":"Tamboli D, Topham A, Singh N, Singh AD. Retinoblastoma: a SEER dataset evaluation for treatment patterns, survival, and second malignant neoplasms. Am J Ophthalmol. 2015;160:953\u20138.","journal-title":"Am J Ophthalmol"},{"key":"687_CR12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","volume":"19","author":"KK Turaga","year":"2012","unstructured":"Turaga KK, Pappas SG, Gamblin T. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379\u201385.","journal-title":"Ann Surg Oncol"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1096-9098(200012)75:4<306::AID-JSO14>3.0.CO;2-3","volume":"75","author":"N Habal","year":"2000","unstructured":"Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000;75:310\u20136.","journal-title":"J Surg Oncol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-016-0687-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:02:57Z","timestamp":1498327377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-016-0687-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s12664-016-0687-3","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}